Postdoctoral researcher in Diabetes and Metabolism Group at Vall d'Hebron Research Institute
Vall d'Hebrón Research institute
Barcelona, Catalonia, Spain
Anne-Katrin Sjolie Best Student Abstract Prize
EAsDEC
Oral presentation. Ramos H; Bogdanov P; Huerta J; Sabater D; Hernández C; Simó R. Transcriptomic analysis reveals that retinal neuromodulation is the main underlying mechanism of the neuroprotective effect of sitagliptin in diabetic retina. 32nd EAsDEC Meeting. 28/05/2022. Belfast, United Kingdom.
Best comunication in the predoctoral category.
Vall d'Hebrón Research Institute (VHIR)
Oral presentation. Ramos H; Bogdanov P; Huerta J; Sabater D; Simó R; Hernández C. Topical ocular administration of sitagliptin, a DPP-4 inhibitor, prevents the downregulation of neuroretinal presynaptic proteins induced by diabetes. 15th Scientific Meeting of VHIR. 14/12/2021. Barcelona, Spain.
Best communication in the postdoctoral category
Vall d'Hebrón Research Institute (VHIR)
Oral presentation. Ramos H; Augustine J; Karan BM; Hernández C; Stitt AW; Curtis TM; Simó R. Inhibition of dipeptidyl peptidase-4 prevents diabetic retinopathy-like lesions in the new non-diabetic Trpv2+/- rat model. 18th Scientific Meeting of VHIR. 04/10/2024. Barcelona, Spain.